Carregant...
Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection
Microdose administration of ABY-029, an anti-epidermal growth factor receptor Affibody molecule conjugated to IRDye 800CW, is being studied in a Phase 0 trial for resection of soft-tissue sarcomas. The excised tissue of a single patient in the microdose administration group was imaged with both a wi...
Guardat en:
| Publicat a: | Proc SPIE Int Soc Opt Eng |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6783124/ https://ncbi.nlm.nih.gov/pubmed/31595101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1117/12.2510935 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|